These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 21676920)

  • 1. Cognitive dysfunction in SLE: development of a screening tool.
    Adhikari T; Piatti A; Luggen M
    Lupus; 2011 Oct; 20(11):1142-6. PubMed ID: 21676920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for cognitive dysfunction in systemic lupus erythematosus: the Montreal Cognitive Assessment Questionnaire and the Informant Questionnaire on Cognitive Decline in the Elderly.
    Chalhoub NE; Luggen ME
    Lupus; 2019 Jan; 28(1):51-58. PubMed ID: 30482092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of computerized assessment to predict neuropsychological functioning and emotional distress in patients with systemic lupus erythematosus.
    Roebuck-Spencer TM; Yarboro C; Nowak M; Takada K; Jacobs G; Lapteva L; Weickert T; Volpe B; Diamond B; Illei G; Bleiberg J
    Arthritis Rheum; 2006 Jun; 55(3):434-41. PubMed ID: 16739211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for cognitive impairment in systemic lupus erythematosus: Application of the Montreal Cognitive Assessment (MoCA) in a Greek patient sample.
    Papastefanakis E; Dimitraki G; Ktistaki G; Fanouriakis A; Karamaouna P; Bardos A; Kallitsakis I; Adamichou C; Gergianaki I; Repa A; Bertsias G; Sidiropoulos P; Karademas E; Simos P
    Lupus; 2021 Dec; 30(14):2237-2247. PubMed ID: 34861804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validity Evidence for the Use of Automated Neuropsychologic Assessment Metrics As a Screening Tool for Cognitive Impairment in Systemic Lupus Erythematosus.
    Tayer-Shifman OE; Green R; Beaton DE; Ruttan L; Wither JE; Tartaglia MC; Kakvan M; Lombardi S; Anderson N; Su J; Bonilla D; Zandy M; Choi MY; Fritzler MJ; Touma Z
    Arthritis Care Res (Hoboken); 2020 Dec; 72(12):1809-1819. PubMed ID: 31628718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the Utility of the Montreal Cognitive Assessment in Screening for Cognitive Impairment in Patients With Systemic Lupus Erythematosus.
    Tayer-Shifman OE; Yuen K; Green R; Kakvan M; Katz P; Bingham KS; Diaz-Martinez JP; Ruttan L; Wither JE; Tartaglia MC; Su J; Bonilla D; Choi MY; Appenzeller S; Barraclough M; Beaton DE; Touma Z
    Arthritis Care Res (Hoboken); 2023 Mar; 75(3):569-577. PubMed ID: 35724303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive function in a systemic lupus erythematosus inception cohort.
    Petri M; Naqibuddin M; Carson KA; Sampedro M; Wallace DJ; Weisman MH; Holliday SL; Padilla PA; Brey RL
    J Rheumatol; 2008 Sep; 35(9):1776-81. PubMed ID: 18634154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of Screening Tests for Cognitive Impairment in Systemic Lupus Erythematosus.
    Nantes SG; Su J; Dhaliwal A; Colosimo K; Touma Z
    J Rheumatol; 2017 Nov; 44(11):1583-1589. PubMed ID: 28864643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Montreal cognitive assessment as a screening instrument for cognitive impairment in systemic lupus erythematosus patients without overt neuropsychiatric manifestations.
    Lim XR; Chew POK; Lim GH; Low YL; Lim JWP; Ong HN; Law WG; Tan JWL; Thong BY; Chia FL; Lian TY; Chan GYL; Chan MT; Koh ET; Kong KO; Howe HS
    Lupus; 2022 Dec; 31(14):1759-1769. PubMed ID: 36218127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial validation of the Pediatric Automated Neuropsychological Assessment Metrics for childhood-onset systemic lupus erythematosus.
    Brunner HI; Ruth NM; German A; Nelson S; Passo MH; Roebuck-Spencer T; Ying J; Ris D
    Arthritis Rheum; 2007 Oct; 57(7):1174-82. PubMed ID: 17907235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in SLE.
    Raghunath S; Glikmann-Johnston Y; Morand E; Stout JC; Hoi A
    Lupus Sci Med; 2021 Dec; 8(1):. PubMed ID: 34911821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for cognitive impairment in systemic lupus erythematosus.
    Hanly JG; Su L; Omisade A; Farewell VT; Fisk JD
    J Rheumatol; 2012 Jul; 39(7):1371-7. PubMed ID: 22660804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of cognitive function in systemic lupus erythematosus, rheumatoid arthritis, and multiple sclerosis by computerized neuropsychological tests.
    Hanly JG; Omisade A; Su L; Farewell V; Fisk JD
    Arthritis Rheum; 2010 May; 62(5):1478-86. PubMed ID: 20155829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the prevalence of cognitive impairment in lupus and which instruments are used to measure it? A systematic review and meta-analysis.
    Rayes HA; Tani C; Kwan A; Marzouk S; Colosimo K; Medina-Rosas J; Mustafa A; Su J; Lambiris P; Mosca M; Touma Z
    Semin Arthritis Rheum; 2018 Oct; 48(2):240-255. PubMed ID: 29571540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Montreal Cognitive Assessment Test: A Useful Tool in Screening of Cognitive Impairment in Patients With Systemic Lupus Erythematosus.
    Paez-Venegas N; Jordan-Estrada B; Chavarria-Avila E; Perez-Vazquez F; Gómez-Bañuelos E; Medina-Dávalos R; Ontiveros-González JÁ; Diaz-Rubio GI; Navarro-Hernandez RE; Vázquez-Del Mercado M
    J Clin Rheumatol; 2019 Dec; 25(8):325-328. PubMed ID: 31764492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validating a computerized neuropsychological test battery for mixed ethnic lupus patients.
    Holliday SL; Navarrete MG; Hermosillo-Romo D; Valdez CR; Saklad AR; Escalante A; Brey RL
    Lupus; 2003; 12(9):697-703. PubMed ID: 14514133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Executive dysfunction, obsessive-compulsive symptoms, and attention deficit and hyperactivity disorder in Systemic Lupus Erythematosus: Evidence for basal ganglia dysfunction?
    Maciel RO; Ferreira GA; Akemy B; Cardoso F
    J Neurol Sci; 2016 Jan; 360():94-7. PubMed ID: 26723981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of cognitive impairment using the Montreal Cognitive Assessment questionnaire among patients with systemic lupus erythematosus: a cross-sectional study at two tertiary centres in Malaysia.
    Kanapathy A; Nik Jaafar NR; Shaharir SS; Chan LF; Rozita M; Ch'ng SS
    Lupus; 2019 Jun; 28(7):854-861. PubMed ID: 31159651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the Montreal Cognitive Assessment superior to the Mini-Mental State Examination to detect poststroke cognitive impairment? A study with neuropsychological evaluation.
    Godefroy O; Fickl A; Roussel M; Auribault C; Bugnicourt JM; Lamy C; Canaple S; Petitnicolas G
    Stroke; 2011 Jun; 42(6):1712-6. PubMed ID: 21474808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the automated neuropsychological assessment metrics for assessing cognitive impairment in systemic lupus erythematosus.
    Yuen K; Beaton D; Bingham K; Katz P; Su J; Diaz Martinez JP; Tartaglia MC; Ruttan L; Wither JE; Kakvan M; Anderson N; Bonilla D; Choi MY; Fritzler MJ; Green R; Touma Z
    Lupus; 2022 Jan; 31(1):45-54. PubMed ID: 34957878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.